Ocular therapy

Details Ocular therapy Ocular therapy

2007-09-11

2007-09-11

Fay, Zohreh (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S912000

Reexamination Certificate

active

10704297

ABSTRACT:
A method for treating a subject suffering from epiretinal membrane formation or retinal detachment due to epiretinal membrane formation is disclosed. The method comprises administering a compound of the formula:whereinn is 0 to 2,R is H or lower alkyl;X is imino, oxa, or thia;Y is aryl; andZ is unsubstituted or substituted pyridyl,an N-oxide thereof, wherein 1 or more N atoms carry an oxygen atom,or a salt thereof.

REFERENCES:
patent: 6258812 (2001-07-01), Bold et al.
patent: 6514974 (2003-02-01), Bold et al.
patent: 6710047 (2004-03-01), Bold et al.
patent: 2003/0171375 (2003-09-01), Brazzell
patent: WO97/34876 (1997-09-01), None
patent: WO97/34920 (1997-09-01), None
patent: WO98/35958 (1998-08-01), None

Affiliated with

Also associated with

Rating

Ocular therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3764128